Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolactin release in polycystic ovary.

P Falaschi, E del Pozo, A Rocco

    Obstetrics and Gynecology
    |May 1, 1980
    PubMed
    Summary

    Polycystic ovary syndrome (PCO) patients showed heightened prolactin (PRL) release in response to TRH and haloperidol tests. Hyperprolactinemic PCO patients exhibited excessive PRL discharge, suggesting estrogen and dopamine system involvement.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparison between different referral strategies for acute ischemic stroke patients in a hub-spoke emergency stroke network: a real-world experience in south-east Lazio.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023
    Same author

    Plasma dosage of ghrelin, IGF-1, GLP- 1 and leptin related to gastric emptying and esophageal pH-impedance in children with obesity.

    Journal of endocrinological investigation·2020
    Same author

    The cortisol burden in elderly subjects with metabolic syndrome and its association with low-grade inflammation.

    Aging clinical and experimental research·2019
    Same author

    Safety of apnea testing for the diagnosis of brain death: a comprehensive study on neuromonitoring data and blood gas analysis.

    European journal of neurology·2019
    Same author

    A global call to action to improve the care of people with fragility fractures.

    Injury·2018
    Same author

    Mental and physical effects of energy drinks consumption in an Italian young people group: a pilot study.

    Journal of preventive medicine and hygiene·2018

    Area of Science:

    • Endocrinology
    • Reproductive Medicine
    • Neuroendocrinology

    Background:

    • Polycystic ovary syndrome (PCO) is frequently associated with endocrine dysregulation.
    • Hyperprolactinemia, elevated prolactin levels, can coexist with PCO, impacting reproductive health.
    • The interplay between PCO, hyperprolactinemia, and the dopaminergic system requires further elucidation.

    Purpose of the Study:

    • To investigate prolactin (PRL) release patterns in response to stimulatory tests in patients with PCO.
    • To compare PRL responses between normoprolactinemic and hyperprolactinemic PCO patients and those with idiopathic hyperprolactinemia.
    • To explore the potential roles of estrogen and the dopaminergic system in PCO-associated hyperprolactinemia.

    Main Methods:

    • Ten normoprolactinemic and 10 hyperprolactinemic PCO patients underwent intravenous TRH and intramuscular haloperidol stimulation tests.

    Related Experiment Videos

  • Hormonal profiles, including luteinizing hormone, estrone, testosterone, and estradiol, were assessed.
  • Results were compared with 8 women with idiopathic hyperprolactinemia and 10 normal female volunteers.

    • Main Results:

    • Both PCO groups demonstrated significantly higher PRL responses to TRH and haloperidol compared to controls (P < .001).
    • Hyperprolactinemic PCO patients showed an excessive PRL discharge (P < .001), unlike idiopathic hyperprolactinemia patients where responses were blunted.
    • Distinctive PCO features included elevated luteinizing hormone, estrone, and testosterone with normal estradiol.

    Conclusions:

    • Patients with PCO exhibit an enhanced PRL release mechanism, irrespective of baseline prolactin levels.
    • The dopaminergic system and estrogen levels may play crucial roles in the pathogenesis of hyperprolactinemia in PCO.
    • These findings highlight potential therapeutic targets for managing PCO-associated endocrine disturbances.